Autophagy in Antiviral Immunity

抗病毒免疫中的自噬

基本信息

  • 批准号:
    7981621
  • 负责人:
  • 金额:
    $ 39.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-01 至 2015-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Autophagy is an ancient evolutionarily conserved pathway designed to maintain cellular homeostasis by degrading long-lived proteins and organelles in the cytosol. It is also used as a survival mechanism under starvation conditions. Recent studies demonstrated that autophagy is utilized by the cells of the innate and adaptive immune systems to combat viral infections. Innate recognition of viruses occurs via two distinct pathways. In professional viral sensors, the plasmacytoid dendritic cells (pDC), recognition of viruses occurs in the endosomes via Toll-like receptors (TLR) 7 and 9. Our recent work has demonstrated that autophagy plays a key role in recognizing signatures of viral infection in pDCs through TLR7. In contrast to pDCs, most other cell types of the body utilize cytosolic sensors of viral replication via RIG-I like receptor (RLR) family. Molecules involved in autophagy have been shown to block RLR signaling. In addition, recent reports indicate that autophagy delivers endogenous viral antigens to the MHC class II loading compartment, allowing activation of CD4 T cells. However, the relevance of such pathways during in vivo virus infection is unknown. In this application, we present preliminary data that reveal the requirement for Atg5, a key molecule required for formation of autophagosomes, in the transduction of signaling through TLR9 leading to the activation of type I IFN genes in pDCs upon herpes simplex virus (HSV; TLR9 agonist) infection. In addition, we show that autophagy negatively regulates RLR pathway in non-plasmacytoid dendritic cells upon vesicular stomatitis virus infection (VSV; RIG-I agonist). Finally, we demonstrate a key in vivo role for autophagy in the processing and presentation of various forms of antigens on MHC class II in dendritic cells upon HSV-1 infection. Building on these preliminary studies, we propose to examine the importance of autophagy in both innate and adaptive immune responses using a variety of molecular and cell biological techniques and using established mouse models of virus infection. In the first Aim, we will determine the mechanism by which Atg5 and/or autophagy mediates signaling through TLR9 upon HSV infection in pDCs through the use of molecular and cellular biological techniques. In the second Aim, we propose to determine how autophagy regulates RNA sensor activation upon VSV infection through proteomics and biochemical approaches. In the final Aim, we will interrogate how dendritic cells utilize autophagy for processing and presentation of extracellular viral antigens in vitro and in vivo in mice selectively deficient in autophagy within the dendritic cell populations. By providing basic understanding of how autophagy orchestrates the generation of innate and adaptive immunity against virus infections, these studies will help to establish important foundation with which to design vaccines and anti-infective measures against a variety of viral pathogens PUBLIC HEALTH RELEVANCE: While autophagy is an ancient evolutionarily conserved pathway designed to maintain cellular homeostasis by degrading long-lived proteins and organelles in the cytosol, recent studies from our group and others have revealed the role of autophagy in the immune system. In this application, we propose to examine the importance of autophagy in both innate and adaptive antiviral immune responses using well-established genetic, biochemical and cell biological tools as well as in vivo animal models of both RNA and DNA virus infections. The understanding gained from the proposed studies will not only provide scientific advances in how autophagy is utilized by the immune system, but also to help establish critical foundation with which to design immunological interventions and preventative measures against a wide variety of viral diseases.
描述(由申请人提供):自噬是一种古老的进化保守途径,旨在通过降解细胞质中的长寿命蛋白质和细胞器来维持细胞稳态。它也被用作饥饿条件下的生存机制。最近的研究表明,先天性和适应性免疫系统的细胞利用自噬来对抗病毒感染。病毒的先天识别通过两种不同的途径发生。在专业的病毒传感器——浆细胞样树突状细胞(pDC)中,病毒的识别通过Toll样受体(TLR)7和9发生在核内体中。我们最近的工作表明,自噬在通过TLR7识别pDC中病毒感染特征方面发挥着关键作用。与 pDC 相比,身体的大多数其他细胞类型通过 RIG-I 样受体 (RLR) 家族利用病毒复制的胞质传感器。参与自噬的分子已被证明可以阻断 RLR 信号传导。此外,最近的报告表明,自噬将内源性病毒抗原传递至 MHC II 类装载室,从而激活 CD4 T 细胞。然而,这些途径在体内病毒感染过程中的相关性尚不清楚。在本申请中,我们提供的初步数据揭示了 Atg5 的需求,Atg5 是自噬体形成所需的关键分子,通过 TLR9 进行信号转导,导致单纯疱疹病毒(HSV;TLR9 激动剂)感染后 pDC 中 I 型 IFN 基因的激活。此外,我们还发现,在水泡性口炎病毒(VSV;RIG-I 激动剂)感染后,自噬对非浆细胞样树突状细胞中的 RLR 通路产生负向调节。最后,我们证明了自噬在 HSV-1 感染后树突状细胞中 MHC II 类各种形式抗原的加工和呈递中的关键体内作用。在这些初步研究的基础上,我们建议使用各种分子和细胞生物学技术以及已建立的病毒感染小鼠模型来检查自噬在先天性和适应性免疫反应中的重要性。在第一个目标中,我们将通过使用分子和细胞生物学技术确定 pDC 中 HSV 感染时 Atg5 和/或自噬通过 TLR9 介导信号传导的机制。在第二个目标中,我们建议通过蛋白质组学和生化方法确定自噬如何在 VSV 感染时调节 RNA 传感器激活。在最终目标中,我们将探讨树突状细胞群中选择性缺乏自噬的小鼠体内和体外如何利用自噬来处理和呈递细胞外病毒抗原。通过提供对自噬如何协调针对病毒感染的先天性和适应性免疫的产生的基本了解,这些研究将有助于为设计针对各种病毒病原体的疫苗和抗感染措施奠定重要基础 公共健康相关性:虽然自噬是一种古老的进化保守途径,旨在通过降解细胞质中的长寿命蛋白质和细胞器来维持细胞稳态,但我们小组和其他人最近的研究揭示了自噬在免疫系统中的作用。在此应用中,我们建议使用成熟的遗传、生化和细胞生物学工具以及 RNA 和 DNA 病毒感染的体内动物模型来检查自噬在先天性和适应性抗病毒免疫反应中的重要性。从拟议的研究中获得的理解不仅将为免疫系统如何利用自噬提供科学进展,而且有助于为设计针对多种病毒性疾病的免疫干预和预防措施奠定重要基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AKIKO IWASAKI其他文献

AKIKO IWASAKI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AKIKO IWASAKI', 18)}}的其他基金

Role of viral infections in potassium channel-related cerebellar ataxia
病毒感染在钾通道相关小脑共济失调中的作用
  • 批准号:
    10412975
  • 财政年份:
    2019
  • 资助金额:
    $ 39.25万
  • 项目类别:
Role of viral infections in potassium channel-related cerebellar ataxia
病毒感染在钾通道相关小脑共济失调中的作用
  • 批准号:
    10019610
  • 财政年份:
    2019
  • 资助金额:
    $ 39.25万
  • 项目类别:
Role of viral infections in potassium channel-related cerebellar ataxia
病毒感染在钾通道相关小脑共济失调中的作用
  • 批准号:
    10183352
  • 财政年份:
    2019
  • 资助金额:
    $ 39.25万
  • 项目类别:
Role of viral infections in potassium channel-related cerebellar ataxia
病毒感染在钾通道相关小脑共济失调中的作用
  • 批准号:
    10640848
  • 财政年份:
    2019
  • 资助金额:
    $ 39.25万
  • 项目类别:
B cell based protection against recurrent herpes
基于 B 细胞的针对复发性疱疹的保护
  • 批准号:
    9380483
  • 财政年份:
    2017
  • 资助金额:
    $ 39.25万
  • 项目类别:
B cell based protection against recurrent herpes
基于 B 细胞的针对复发性疱疹的保护
  • 批准号:
    9926219
  • 财政年份:
    2017
  • 资助金额:
    $ 39.25万
  • 项目类别:
Innate antiviral defense against Vaginal transmission of ZIKA virus
针对寨卡病毒阴道传播的先天抗病毒防御
  • 批准号:
    9320403
  • 财政年份:
    2017
  • 资助金额:
    $ 39.25万
  • 项目类别:
B cell based protection against recurrent herpes
基于 B 细胞的针对复发性疱疹的保护
  • 批准号:
    10161710
  • 财政年份:
    2017
  • 资助金额:
    $ 39.25万
  • 项目类别:
Inflammasomes as innate link to antiviral immunity
炎症小体与抗病毒免疫的先天联系
  • 批准号:
    8334243
  • 财政年份:
    2011
  • 资助金额:
    $ 39.25万
  • 项目类别:
Autophagy in Antiviral Immunity
抗病毒免疫中的自噬
  • 批准号:
    8662163
  • 财政年份:
    2010
  • 资助金额:
    $ 39.25万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 39.25万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 39.25万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 39.25万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 39.25万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 39.25万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 39.25万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 39.25万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 39.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了